In addition, additional experiments are needed to evaluate the relationship between DNTTIP1 expression and clinical features, HCC stage, and prognosis using additional clinical data, which might facilitate the identification of new markers for evaluating tumor stage, aiding drug development, and improving treatment efficiency. This evidence concerns the gene DNTTIP1 and neoplasm.